首页> 外国专利> COMPOSITION FOR PREVENTING CONTACT DERMATITIS CONTAINING BARRIER FILM AND METHOD FOR PREVENTING CONTACT DERMATITIS

COMPOSITION FOR PREVENTING CONTACT DERMATITIS CONTAINING BARRIER FILM AND METHOD FOR PREVENTING CONTACT DERMATITIS

机译:防止包含阻挡膜的接触性皮肤的组合物和预防接触性皮肤的方法

摘要

1. A composition for preventing or reducing contact dermatitis which comprises: (1) a polysaccharide; (2) a low molecular weight, synergistic saccharide; (3) a solvent; and (4) optionally physiologically and psychologically favourable an additive agent. 2. The composition of claim 1 further comprises an antimicrobial agent wherein said polysaccharide is a cellulose derivative. 3. The composition of claim 1, wherein said polysaccharide is a cellulose derivative. 4. The composition of claim 3, wherein said cellulose derivative is selected from the group consisting of methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxybutylcellulose, methylhydroxyethylcellulose, methylhydroxypropylcellulose, methylhydroxybutylcellulose, hydroxyethylhydroxypropylcellulose, and ethylhydroxyethylcellulose. 5. The composition of claim 1, wherein said polysaccharide is hydroxypropylcellulose. 6. The composition of claim 1, wherein said low molecular weight, synergistic saccharide is selected from the group consisting of unmodified monosaccharide, derivatized monosaccharide, unmodified disaccharide, derivatized disaccharide, hydrolyzed starch, and derivatized starch hydrolysate. 7. The composition of claim 6, wherein said unmodified monosaccharide is selected from the group consisting of fructose, glucose, and mannose. 8. The composition of claim 6 wherein said unmodified disaccharide is selected from the group consisting of sucrose and maltose. 9. The composition of claim 6, wherein said derivatized monosaccharide is selected from the group consisting of ethoxylates of methyl glucoside, propox ylates of methyl glucoside, propoxylates of methyl glucoside distearate, and methyl glucose dioleate. 10. The composition of claim 6, wherein derivatized monosaccharide is about 20 mole ethoxylate of methyl glucoside. 11. The composition of claim 6, wherein said derivatized disaccharide is selected from the group consisting of about 10 mole ethoxylates, about 20 mole ethoxylates, about 10 mole propoxylates, and about 20 mole propoxylates. 12. The composition of claim 6, wherein said hydrolyzed starch is selected from the group consisting of maltodextrin and corn syrup solids. 13. The composition of claim 6, wherein said derivatized starch hydrolyate is selected from the group consisting of about 10 mole ethoxylates, about 20 mole ethoxylates, about 10 mole propoxylates, and about 20 mole propoxylates. 14. The composition of claim 1, wherein said solvent is selected from the group consisting of water, lower alcohols, low molecular weight glycols or mixtures thereof. 15. The composition of claim 1, wherein said additive agent is selected from the group consisting of colorants, fragrances, sunscreen, insect repellants , surfactants, flow modifiers, cleansers, moisturizers, film solubility modifiers, film plasticizers, salts, natural extracts, exfoliants, astringents, antioxidants, vitamins, self-tanning gents, emulsifiers, emollients, enzymes, keratolytics, antipruitics , analgesics, anesthetics, antihistamines, antimicrobial agents, preservatives, antibiotics, a ntiseptics, antifungals, antivirals, and mixtures thereof. 16. The composition of claim 1, wherein said polysaccharide is in the amount of about 5 wt.% to about 20 wt.%, wherein said low molecular weight, synergistic saccharide is in the amount of 2 wt.% to 10 wt.%, wherein said solvent is in the amount of about 70 wt.% to about 93 wt.%, and optionally wherein said additive agent is in the amount of about 0.01 wt.% to about of 30 wt.%. 17. The composition of claim 2, wherein said antimicrobial agent is selected from the group consisting of triclosan, hexetidine, chlorhexidine salts, 2-bromo-2-nitropropane-1,3-diol, hexyresorcinol, benzalkonium chloride, cetylpyridinium chloride, alkylbenzyldimethylammonium chlorides, iodine, phenol derivatives, povidone-iodine, parabens, hydantoins, hydantoins derivatives, phenoxyethanol, cis-isomer of 1-(3-chloroallyl)-3,5,6-triaza-1-azoniaadamantane chloride, diazolidinyl urea, benzethonium chloride, methylbenzethonium chloride, and mixtures thereof. 18. The composition of claim 2, wherein said antimicrobial agent is selected from the group consisting of triclosan, cis-isomer of 1-(3-chloroallyl)-3,5,6-triaza-1-azoniaadamantane chloride, hydantoins, hydantoin derivatives, and mixtures thereof. 19. The composition of claim 2, wherein said polysaccharide is in the amount of about 5 wt.% to about 20 wt.%, wherein said low molecular weight, synergistic saccharide is in the amount of 2 wt.% to 10 wt.%, wherein said antimicrobial agent is in the amount of about 0.1 wt.% to about 2 wt.%, wherein said solvent is in the amount of about 70 wt.% to about 93 wt.%, and optionally where in said additive is in the amount of about 0.01 wt.% to about of 30 wt.%. 20. A method for preventing or reducing contact dermatitis which comprises: applying a dermatologically-compatible barrier film composition to skin of mammals wherein said composition comprises (1) a polysaccharide; (2) a low molecular weight, synergistic saccharide; (3) a solvent; and (4) optionally an additive agent. 21. The method of claim 20, wherein said composition further comprises an antimicrobial agent. 22. The method of claim 20, wherein said polysaccharide is a cellulose derivative. 23. The method according to claim 22, wherein said cellulose is selected from the group consisting of methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxybutylcellulose, methylhydroxyethylcellulose, methylhydroxypropylcellulose, methylhydroxybutylcellulose, hydroxyethylhydroxypropylcellulose, and ethylhydroxyethylcellulose. 24. The method of claim 20, wherein said polysaccharide is hydroxypropylcellulose. 25. The method of claim 20, wherein said low molecular weight, synergistic saccharide is selected from the group consisting of unmodified monosaccharide, derivatized monosaccharide, unmodified disaccharide, derivatized disaccharide, hydrolyzed starch, and derivatized starch hydrolysate. 26. The method of claim 25, wherein said unmodified monosaccharide is selected from the group consisting of fructose, glucose, and mannose. 27. The method of claim 25, wherein said unmodified disaccharide is selected from the group consisting of sucrose and maltose. 28. The method of claim 25, wherein said derivatized monosaccharide is selected from the group consisting of ethoxylates of methyl glucoside, propoxyla tes of methyl glucoside, propoxylates of methyl glucoside distearate, and methyl glucos e dioleate. 29. The method of claim 25, wherein derivatized monosaccharide is about 20 mole ethoxylate of methyl glucoside. 30. The method of claim 25, wherein said derivatized disaccharide is selected from the group consisting of about 10 mole ethoxylates, about 20 mole ethoxylates, about 10 mole propoxylates, and about 20 mole propoxylates. 31. The method of claim 25, wherein said hydrolyzed starch is selected from the group consisting of maltodextrin and corn syrup solids. 32. The method of claim 25, wherein said derivatized starch hydrolysate is selected from the group consisting of about 10 mole ethoxylates, about 20 mole ethoxylates, about 10 mole propoxylates, and about 20 mole propoxylates. 33. The method of claim 20 wherein said solvent is selected from the group consisting of water, lower alcohols, low molecular weight glycols or mixtures thereof. 34. The composition of claim 20, wherein said additive agent is selected from the group consisting of colorants, fragrances, sunscreen, insect repellants , surfactants, flow modifiers, cleansers, moisturizers, water resistant compounds, salts, natural extracts, exfoliants, astringents, antioxidants, vitamins, self-tanning gents, emulsifiers, emollients, enzymes, keratolytics, antipruitics, analgesics, anesth etics, antihistamines, antimicrobial agents, preservatives, antibiotics, antiseptics, a ntifungals, antivirals, and mixtures thereof. 35. The method of claim 20, wherein said polysaccharide is in the amount of about 5 wt.% to about 20 wt.%, wherein said low molecular weight, synergistic saccharide is in the amount of about 2 wt.% to about 10 wt.%, wherein said solve nt is in the amount of about 70 wt.% to about 93 wt.%, and optionally wherein said additive agent is in the amount of about 0.01 wt.% to about of 30 wt.%. 36. The method of claim 21, wherein said antimicrobial agent is selected from the group consisting of triclosan, hexetidine, chlorhexidine salts, 2-bromo nitropropane-1,3-diol, hexyresorcinol, benzalkonium chloride, cetylpyridinium chloride, alkylbenzyldimethylammonium chlorides, iodine, phenol derivatives, povidone-iodine, parabens, hydantoins, hydantoins derivatives, phenoxyethanol, cis-isomer of 1-(3-chloroallyl)-3,5,6-triaza-1-azoniaadamantane chloride, diazolidinyl urea, benzethonium chloride, methylbenzethonium chloride, and mixtures thereof. 37. The method of claim 21, wherein said antimicrobial agent is selected from the group consisting of triclosan, cis-isomer of 1-(3-chloroallyl)-3,5,6-triaza-1-azoniaadamantane chloride, hydantoins, hydantoin derivatives, and mixtures there of. 38. The method of claim 22, wherein said polysaccharide is in the amount of about 5 wt.% to about 20 wt.%, wherein said low molecular weight, synergistic saccharide is in the amount of about 2 wt.% to about 10 wt.%, wherein said antimicrobial agent is in the amount of about 0.1 wt.% to about 2 wt.%, wherein said solvent is in the amount of about 70 wt.% to about 93 wt.%, and optionally where in said additive agent is in the amount of about 0.01 wt.% to about of 30 wt.%. 39. A dermatologically-compatible barrier film comprising: (1) a polysaccharide; (2) a low molecular weight, synergistic saccharide; and (3) optionally an additive agent. 40. The dermatologically-compatible barrier film of claim 39 further comprises an antimicrobial agent. 41. The dermatologically-compatible barrier film of claim 39, wherein sa
机译:1.一种用于预防或减轻接触性皮炎的组合物,其包含:(1)多糖; (2)低分子量协同糖; (3)溶剂; (4)任选地在生理和心理上有利的添加剂。 2.权利要求1的组合物,其还包含抗微生物剂,其中所述多糖是纤维素衍生物。 3.权利要求1的组合物,其中所述多糖是纤维素衍生物。 4.权利要求3的组合物,其中所述纤维素衍生物选自甲基纤维素,乙基纤维素,羟乙基纤维素,羟丙基纤维素,羟丁基纤维素,甲基羟乙基纤维素,甲基羟丙基纤维素,甲基羟丁基纤维素,羟乙基羟丙基纤维素和乙基羟乙基纤维素。 5.权利要求1的组合物,其中所述多糖是羟丙基纤维素。 6.权利要求1的组合物,其中所述低分子量协同糖选自未修饰的单糖,衍生的单糖,未修饰的二糖,衍生的二糖,水解淀粉和衍生的淀粉水解产物。 7.权利要求6的组合物,其中所述未修饰的单糖选自果糖,葡萄糖和甘露糖。 8.权利要求6的组合物,其中所述未修饰的二糖选自蔗糖和麦芽糖。 9.权利要求6的组合物,其中所述衍生化的单糖选自甲基葡糖苷的乙氧基化物,甲基葡糖苷的丙氧基化物,葡糖苷二硬脂酸甲酯的丙氧基化物和葡萄糖基二油酸酯。 10.权利要求6的组合物,其中衍生的单糖是甲基葡糖苷的约20摩尔乙氧基化物。 11.权利要求6的组合物,其中所述衍生化的二糖选自约10摩尔的乙氧基化物,约20摩尔的乙氧基化物,约10摩尔的丙氧基化物和约20摩尔的丙氧基化物。 12.权利要求6的组合物,其中所述水解淀粉选自麦芽糖糊精和玉米糖浆固体。 13.权利要求6的组合物,其中所述衍生的淀粉水解产物选自约10摩尔的乙氧基化物,约20摩尔的乙氧基化物,约10摩尔的丙氧基化物和约20摩尔的丙氧基化物。 14.权利要求1的组合物,其中所述溶剂选自水,低级醇,低分子量二醇或其混合物。 15.权利要求1的组合物,其中所述添加剂选自着色剂,香料,防晒剂,驱虫剂,表面活性剂,流动改性剂,清洁剂,保湿剂,膜溶解性改性剂,膜增塑剂,盐,天然提取物,去角质剂。 ,收敛剂,抗氧化剂,维生素,自晒黑剂,乳化剂,润肤剂,酶,角质层分离剂,镇静剂,镇痛剂,麻醉剂,抗组胺药,抗微生物剂,防腐剂,抗生素,抗菌剂,抗炎药,抗真菌剂,抗病毒剂及其混合物。 16.权利要求1的组合物,其中所述多糖的量为约5重量%至约20重量%,其中所述低分子量协同糖的量为2重量%至10重量%。 ,其中所述溶剂的量为约70wt。%至约93wt。%,并且任选地其中所述添加剂的量为约0.01wt。%至约30wt。%。 17.根据权利要求2所述的组合物,其中所述抗微生物剂选自三氯生,己定,氯己定盐,2-溴-2-硝基丙烷-1,3-二醇,己基间苯二酚,苯扎氯铵,十六烷基吡啶鎓氯化物,烷基苄基二甲基氯化铵。 ,碘,苯酚衍生物,聚维酮碘,对羟基苯甲酸酯,乙内酰脲,乙内酰脲衍生物,苯氧乙醇,1-(3-氯烯丙基)-3,5,6-三氮杂-1-氮杂十二烷金刚烷的顺式异构体,重氮烷基脲,苄索氯铵,甲基苄索氯铵及其混合物。 18.权利要求2的组合物,其中所述抗微生物剂选自三氯生,1-(3-氯烯丙基)-3,5,6-三氮杂-1-氮杂金刚烷酰氯的顺式异构体,乙内酰脲,乙内酰脲衍生物。 ,及其混合物。 19.权利要求2的组合物,其中所述多糖的量为约5重量%至约20重量%,其中所述低分子量协同糖的量为2重量%至10重量%。 ,其中所述抗微生物剂的量为约0.1wt。%至约2wt。%,其中所述溶剂的量为约70wt。%至约93wt。%。任选地,其中所述添加剂的含量为约0.01重量%至约30重量%。 20.一种预防或减少接触性皮炎的方法,该方法包括:将与皮肤学相容的屏障膜组合物施用于哺乳动物的皮肤,其中所述组合物包含(1)多糖;和(2)低分子量协同糖; (3)溶剂; (4)任选地添加剂。 21.权利要求20的方法,其中所述组合物还包含抗微生物剂。 22.权利要求20的方法,其中所述多糖是纤维素衍生物。 23.根据权利要求22所述的方法,其中,所述纤维素选自甲基纤维素,乙基纤维素,羟乙基纤维素,羟丙基纤维素,羟丁基纤维素,甲基羟乙基纤维素,甲基羟丙基纤维素,甲基羟丁基纤维素,羟乙基羟丙基纤维素和乙基羟乙基纤维素。 24.权利要求20的方法,其中所述多糖是羟丙基纤维素。 25.权利要求20的方法,其中所述低分子量协同糖选自未修饰的单糖,衍生的单糖,未修饰的二糖,衍生的二糖,水解淀粉和衍生的淀粉水解物。 26.权利要求25的方法,其中所述未修饰的单糖选自果糖,葡萄糖和甘露糖。 27.权利要求25的方法,其中所述未修饰的二糖选自蔗糖和麦芽糖。 28.根据权利要求25所述的方法,其中所述衍生化的单糖选自甲基葡糖苷的乙氧基化物,甲基葡糖苷的丙氧基酯,葡糖苷二硬脂酸甲酯的丙氧基化物和甲基葡糖酸二油酸酯。 29.权利要求25的方法,其中衍生的单糖是甲基葡糖苷的约20摩尔乙氧基化物。 30.权利要求25的方法,其中所述衍生的二糖选自约10摩尔的乙氧基化物,约20摩尔的乙氧基化物,约10摩尔的丙氧基化物和约20摩尔的丙氧基化物。 31.权利要求25的方法,其中所述水解淀粉选自麦芽糖糊精和玉米糖浆固体。 32.权利要求25的方法,其中所述衍生的淀粉水解产物选自约10摩尔的乙氧基化物,约20摩尔的乙氧基化物,约10摩尔的丙氧基化物和约20摩尔的丙氧基化物。 33.根据权利要求20所述的方法,其中所述溶剂选自水,低级醇,低分子量二醇或其混合物。 34.权利要求20的组合物,其中所述添加剂选自着色剂,香料,防晒剂,驱虫剂,表面活性剂,流动改性剂,清洁剂,保湿剂,耐水化合物,盐,天然提取物,去角质剂,收敛剂,抗氧化剂,维生素,自晒黑剂,乳化剂,润肤剂,酶,角质层分离剂,镇痛药,止痛药,麻醉剂,抗组胺药,抗微生物剂,防腐剂,抗生素,防腐剂,抗真菌药,抗病毒药及其混合物。 35.权利要求20的方法,其中所述多糖的量为约5wt。%至约20wt。%,其中所述低分子量协同糖的量为约2wt。%至约10wt。%。 %,其中所述溶解nt的量为约70wt%至约93wt%,并且任选地其中所述添加剂的量为约0.01wt%至约30wt%。 36.根据权利要求21所述的方法,其中所述抗微生物剂选自三氯生,己西定,氯己定盐,2-溴硝基丙烷-1,3-二醇,己基间苯二酚,苯扎氯铵,鲸蜡基吡啶鎓氯化物,烷基苄基二甲基氯化铵,碘,苯酚衍生物,聚维酮碘,对羟基苯甲酸酯,乙内酰脲,乙内酰脲衍生物,苯氧基乙醇,1-(3-氯烯丙基)-3,5,6-三氮杂-1-氮杂金刚烷酰氯的顺式异构体,重氮烷基吡啶脲,苄索氯铵,甲基苯并氯铵,及其混合物。 37.根据权利要求21所述的方法,其中所述抗微生物剂选自三氯生,1-(3-氯烯丙基)-3,5,6-三氮杂-1-氮杂金刚烷酰氯的顺式异构体,乙内酰脲,乙内酰脲衍生物。 ,以及那里的混合物。 38.权利要求22的方法,其中所述多糖的量为约5wt。%至约20wt。%,其中所述低分子量协同糖的量为约2wt。%至约10wt。%。 ,其中所述抗微生物剂的量为约0.1重量%至约2重量%,其中所述溶剂为约70重量%至约93重量%。,并且任选地,其中所述添加剂的量为约0.01重量%至约30重量%。 39.一种皮肤病学相容的屏障膜,其包含:(1)多糖; (2)低分子量协同糖; (3)任选地添加剂。 40.根据权利要求39所述的皮肤病学相容性阻挡膜,其还包含抗微生物剂。 41.根据权利要求39所述的皮肤病学相容性屏障膜,其中,

著录项

  • 公开/公告号EA001191B1

    专利类型

  • 公开/公告日2000-12-25

    原文格式PDF

  • 申请/专利权人 HYDROMER INC.;

    申请/专利号EA19980000958

  • 发明设计人 DALLA RIVA TOMA JOAN;CARL CURTIS L.;

    申请日1997-04-28

  • 分类号A61K7/48;

  • 国家 EA

  • 入库时间 2022-08-22 01:25:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号